https://www.zacks.com/stock/news/2258502/analysts-estimate-centene-cnc-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2258502
Apr 19, 2024 - Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:5307242252974664373
0
https://www.zacks.com/stock/news/2260507/watch-these-5-medical-stocks-for-q1-earnings-beat-or-miss?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2260507
Apr 23, 2024 - Improved premiums resulting from membership growth, and higher patient admissions are expected to have driven the Q1 performance of HUM, MOH, UHS, EHC and CYH. An elevated operating expense level is likely to have dented growth prospects.
zc:-4270712098456522730
0
https://www.zacks.com/stock/news/2260440/why-earnings-season-could-be-great-for-humana-hum?cid=CS-ZC-FT-tale_of_the_tape|earnings_surprise-2260440
Apr 23, 2024 - Humana (HUM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
zc:-1917213799915154288
0
https://www.zacks.com/stock/news/2261552/premium-growth-propels-humana-hum-to-easy-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2261552
Apr 24, 2024 - Humana (HUM) bumps up individual Medicare Advantage membership growth guidance.
zc:7573814041588294672
0
https://www.zacks.com/stock/news/2261553/humana-hum-q1-earnings-taking-a-look-at-key-metrics-versus-estimates-revised?cid=CS-ZC-FT-fundamental_analysis|nfm-2261553
Apr 24, 2024 - Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:1363789530965814030
0
https://www.zacks.com/stock/news/2264352/encompass-health-ehc-stock-down-despite-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2264352
Apr 29, 2024 - Encompass Health (EHC) increases its guidance for net operating revenues, which is in the range of $5.25-$5.325 million for 2024.
zc:3070483661695462447
0
https://www.zacks.com/stock/news/2267361/cigna-ci-q1-earnings-beat-on-client-wins-in-evernorth-unit?cid=CS-ZC-FT-analyst_blog|earnings_article-2267361
May 02, 2024 - Cigna's (CI) Q1 results reflect strong organic growth in the Evernorth Health Services unit. It expects adjusted EPS of at least $28.40 for 2024, up from the earlier guidance of at least $28.25.
zc:3047771712818341818
0
https://www.zacks.com/commentary/2267710/4-hmo-stocks-to-watch-amid-persistent-industry-challenges?cid=CS-ZC-FT-industry_outlook-2267710
May 03, 2024 - The Medical-HMO industry continues to witness an expanding customer base resulting from contract wins. However, high technology expenses and a shortage of medical personnel are a concern. UNH, CI, CNC and HUM are likely to navigate industry storms.
zc:-4910032991829822807
0